Intrathecal Rituximab in Treating Patients With Recurrent CNS Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Lymphoma
Related studies linked through entity extraction aliases.
Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Combination Chemotherapy and Rituximab in Treating Patients With Newly Diagnosed Primary CNS Lymphoma
- Status
- COMPLETED
- Phase
- NA
Epoetin Alfa or Darbepoetin Alfa in Treating Patients With Anemia Caused by Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE2
Radiation Therapy or Combination Chemotherapy in Treating Young Patients With Hodgkin's Lymphoma
- Status
- UNKNOWN
- Phase
- NA
Clofarabine in Treating Patients With T-Cell or Natural Killer-Cell Non-Hodgkin's Lymphoma That Has Relapsed or Not Responded to Previous Treatment
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Iodine I 131 Tositumomab or Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- N/A
AMENO-2: Aprepitant Plus Palonosetron Versus Granisetron in the Prevention of Nausea and the Emesis Induced by Chemotherapy in Patients Treated With Haematopoietic Progenitors
- Status
- COMPLETED
- Phase
- PHASE4
Efficacy and Safety of Treatment With a Single Dose of 90Y-ibritumomab Tiuxetan in Patients With Low Tumor Burden Untreated or Indolent NHL
- Status
- WITHDRAWN
- Phase
- PHASE2
Study of Oral PXD101 in Patients With Advanced Solid Tumors or Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Rituximab and GM-CSF in Treating Patients With Newly Diagnosed Follicular B-Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Gemcitabine Plus Busulfan, Melphalan and Hematopoietic Cell Transplant for Advanced Lymphoid Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Alemtuzumab and Glucocorticoids in Treating Newly Diagnosed Acute Graft-Versus-Host Disease in Patients Who Have Undergone a Donor Stem Cell Transplant
- Status
- COMPLETED
- Phase
- PHASE2
Ovarian Damage in Young Premenopausal Women Undergoing Chemotherapy for Cancer
- Status
- WITHDRAWN
- Phase
- N/A
Observation in Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma Treated on Clinical Trial CAN-NCIC-LY9
- Status
- UNKNOWN
- Phase
- N/A
Combination Chemotherapy in Treating Young Male Patients With Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Rituximab, Fludarabine, Cyclophosphamide, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed B-Cell Non-Hodgkin's Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Study of Parathyroid Hormone Following Sequential Cord Blood Transplantation From an Unrelated Donor
- Status
- TERMINATED
- Phase
- PHASE2
Doxorubicin Hydrochloride Liposome and Rituximab With Combination Chemotherapy in Treating Patients With Newly Diagnosed Burkitt's Lymphoma or Burkitt-Like Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Rituximab and Combination Chemotherapy in Treating Patients With Newly Diagnosed, HIV-Associated Burkitt's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2